MariMed Inc (OTCPK:MRMD)

$ 0.255 -0.01 (-3.77%) Market Cap: 96.81 Mil Enterprise Value: 167.64 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 63/100

Q4 2023 MariMed Inc Earnings Call Transcript
Mar 07, 2024

$0.235 (-2.08%)

Earnings
Q3 2023 MariMed Inc Earnings Call Transcript
Nov 09, 2023

$0.3188 (-0.38%)

Earnings
Q2 2023 MariMed Inc Earnings Call Transcript
Aug 03, 2023

$0.366 (-4.36%)

Earnings
Q1 2023 MariMed Inc Earnings Call Transcript
May 09, 2023

$0.49495 (+4.20%)

Earnings
Q4 2022 Marimed Inc Earnings Call Transcript
Mar 02, 2023

$0.445 (+1.14%)

Earnings
MariMed Inc Is Winning Massachusetts Market Share Transcript
Feb 23, 2023
MariMed Inc For The 12 Month Outlook Transcript
Jan 25, 2023
Q3 2022 Marimed Inc Earnings Call Transcript
Nov 08, 2022

$0.51 (-0.86%)

Earnings
Q2 2022 Marimed Inc Earnings Call Transcript
Aug 09, 2022

$0.62476 (-10.75%)

Earnings
Q1 2022 Marimed Inc Earnings Call Transcript
May 11, 2022

$0.6365 (+3.50%)

Earnings
Marimed Inc at Benzinga Cannabis Capital Conference Transcript
Apr 20, 2022
Q3 2021 Marimed Inc Earnings Call Transcript
Nov 16, 2021

$0.845 (-10.11%)

Earnings
Q2 2021 Marimed Inc Earnings Call Transcript
Aug 17, 2021

$0.9895 (+2.99%)

Earnings
Q1 2021 Marimed Inc Earnings Call Transcript
May 18, 2021

$0.83037 (-2.54%)

Earnings
Q4 2020 Marimed Inc Earnings Call Transcript
Mar 24, 2021

$0.83 (-1.19%)

Earnings
Q3 2020 Marimed Inc Earnings Call Transcript
Nov 10, 2020

$0.175 (-7.89%)

Earnings
MariMed Inc Benzinga Virtual Cannabis Capital Conference Transcript
Oct 15, 2020

MariMed Inc For The 12 Month Outlook Transcript

Jan 25, 2023 / NTS GMT

Release Date Price: $0.4 (+5.26%)

Transcript

Shadd Dales

The Dales Report - Moderator

Bob Fireman, CEO, started this company, very, very great person, trailblazer within the industry, passed away last month. First off, I guess the question, who was Bob Fireman and what's the legacy that he leaves behind?

Hey, everyone. Welcome to the Trade to Black podcast. Thanks for checking in. I'm your host, Shadd Dales. Today, as usual, we talk cannabis. It's a brand-new year, a lot of uncertainty pertaining to the industry, but we want to find out what questions you want to know, help calm the nerves and have a better idea as to how 2023 is going to unfold and basically, the action plan that's in place and there's no better person we want to bring in. He's the interim CEO of MariMed, Jon Levine, back to the podcast. Good day and Happy New Year.

Jon Levine

MariMed Inc. - President & Interim CEO

Happy New Year to you also.

Questions & Answers

Shadd Dales

The Dales Report - Moderator

Yes, how are things? I know we're getting ready for -- I think there

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.